Unknown

Dataset Information

0

CDKN2B is critical for verapamil-mediated reversal of doxorubicin resistance in hepatocellular carcinoma.


ABSTRACT: In this study, we explored the function and mechanism of CDKN2B genes in verapamil (VER)-induced reversal of resistance to doxorubicin (ADM) chemotherapy in hepatocellular carcinoma (HCC). We examined 4 HCC cell lines and found that the expression levels of CDKN2B genes correlated with the level of apoptosis induced by ADM+VER. Overexpression of CDKN2B genes promoted apoptosis in cells treated with VER+ADM. CDKN2B knockdown using siRNA weakened the effect of ADM+VER, indicating that ADM+VER promotes HCC cell apoptosis and that CDKN2B genes participate in VER-mediated promotion in tumor cell apoptosis. Future research will further explore the functional mechanism, and the associated signal transduction pathways via which CDKN2B affects HCC drug resistance.

SUBMITTER: Zhang T 

PROVIDER: S-EPMC5746364 | biostudies-literature | 2017 Dec

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC6568175 | biostudies-literature
| S-EPMC5437682 | biostudies-other
| S-EPMC8266889 | biostudies-literature
| S-EPMC7733254 | biostudies-literature
| S-EPMC4854441 | biostudies-literature
| S-EPMC6729091 | biostudies-literature
| S-EPMC6815770 | biostudies-literature
| S-EPMC1173140 | biostudies-literature
| S-EPMC8170002 | biostudies-literature
| S-EPMC8786848 | biostudies-literature